Cargando…

Recent Advances for Dynamic-Based Therapy of Atherosclerosis

Atherosclerosis (AS) is a chronic inflammatory disease, which may lead to high morbidity and mortality. Currently, the clinical treatment strategy for AS is administering drugs and performing surgery. However, advanced therapy strategies are urgently required because of the deficient therapeutic eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Guanghao, Yu, Guanye, Zheng, Meiling, Peng, Wenhui, Li, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352141/
https://www.ncbi.nlm.nih.gov/pubmed/37469455
http://dx.doi.org/10.2147/IJN.S402678
_version_ 1785074454942973952
author Wu, Guanghao
Yu, Guanye
Zheng, Meiling
Peng, Wenhui
Li, Lei
author_facet Wu, Guanghao
Yu, Guanye
Zheng, Meiling
Peng, Wenhui
Li, Lei
author_sort Wu, Guanghao
collection PubMed
description Atherosclerosis (AS) is a chronic inflammatory disease, which may lead to high morbidity and mortality. Currently, the clinical treatment strategy for AS is administering drugs and performing surgery. However, advanced therapy strategies are urgently required because of the deficient therapeutic effects of current managements. Increased number of energy conversion-based organic or inorganic materials has been used in cancer and other major disease treatments, bringing hope to patients with the development of nanomedicine and materials. These treatment strategies employ specific nanomaterials with specific own physiochemical properties (external stimuli: light or ultrasound) to promote foam cell apoptosis and cholesterol efflux. Based on the pathological characteristics of vulnerable plaques, energy conversion-based nano-therapy has attracted increasing attention in the field of anti-atherosclerosis. Therefore, this review focuses on recent advances in energy conversion-based treatments. In addition to summarizing the therapeutic effects of various techniques, the regulated pathological processes are highlighted. Finally, the challenges and prospects for further development of dynamic treatment for AS are discussed.
format Online
Article
Text
id pubmed-10352141
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-103521412023-07-19 Recent Advances for Dynamic-Based Therapy of Atherosclerosis Wu, Guanghao Yu, Guanye Zheng, Meiling Peng, Wenhui Li, Lei Int J Nanomedicine Review Atherosclerosis (AS) is a chronic inflammatory disease, which may lead to high morbidity and mortality. Currently, the clinical treatment strategy for AS is administering drugs and performing surgery. However, advanced therapy strategies are urgently required because of the deficient therapeutic effects of current managements. Increased number of energy conversion-based organic or inorganic materials has been used in cancer and other major disease treatments, bringing hope to patients with the development of nanomedicine and materials. These treatment strategies employ specific nanomaterials with specific own physiochemical properties (external stimuli: light or ultrasound) to promote foam cell apoptosis and cholesterol efflux. Based on the pathological characteristics of vulnerable plaques, energy conversion-based nano-therapy has attracted increasing attention in the field of anti-atherosclerosis. Therefore, this review focuses on recent advances in energy conversion-based treatments. In addition to summarizing the therapeutic effects of various techniques, the regulated pathological processes are highlighted. Finally, the challenges and prospects for further development of dynamic treatment for AS are discussed. Dove 2023-07-13 /pmc/articles/PMC10352141/ /pubmed/37469455 http://dx.doi.org/10.2147/IJN.S402678 Text en © 2023 Wu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Wu, Guanghao
Yu, Guanye
Zheng, Meiling
Peng, Wenhui
Li, Lei
Recent Advances for Dynamic-Based Therapy of Atherosclerosis
title Recent Advances for Dynamic-Based Therapy of Atherosclerosis
title_full Recent Advances for Dynamic-Based Therapy of Atherosclerosis
title_fullStr Recent Advances for Dynamic-Based Therapy of Atherosclerosis
title_full_unstemmed Recent Advances for Dynamic-Based Therapy of Atherosclerosis
title_short Recent Advances for Dynamic-Based Therapy of Atherosclerosis
title_sort recent advances for dynamic-based therapy of atherosclerosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352141/
https://www.ncbi.nlm.nih.gov/pubmed/37469455
http://dx.doi.org/10.2147/IJN.S402678
work_keys_str_mv AT wuguanghao recentadvancesfordynamicbasedtherapyofatherosclerosis
AT yuguanye recentadvancesfordynamicbasedtherapyofatherosclerosis
AT zhengmeiling recentadvancesfordynamicbasedtherapyofatherosclerosis
AT pengwenhui recentadvancesfordynamicbasedtherapyofatherosclerosis
AT lilei recentadvancesfordynamicbasedtherapyofatherosclerosis